• Br J Anaesth · Oct 1988

    Severe bradycardia following propofol-suxamethonium sequence.

    • A Baraka.
    • Department of Anesthesiology, American University of Beirut, Lebanon.
    • Br J Anaesth. 1988 Oct 1;61(4):482-3.

    AbstractAnaesthesia was induced with propofol 2.5 mg kg-1 followed by suxamethonium 1.5 mg kg-1 in six young healthy females undergoing laparoscopy. ECG was monitored continuously. In two unpremedicated patients, this was followed by severe sinus bradycardia, while no bradycardia was observed in the other four patients who were premedicated with atropine 0.6 mg i.m. These observations suggest that propofol-suxamethonium sequence may be followed by severe bradycardia in patients who have not received atropine. The bradycardia may be prevented by premedication with atropine. In contrast to thiopentone, propofol apparently lacks central vagolytic activity and may exert a central vagotonic effect which can exaggerate the muscarinic effects of suxamethonium.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.